ReceptorPharma Inc
Do something of consequent to help the world. Proactively including the scientific boundaries for global breakthroughs
Do something of consequent to help the world. Proactively including the scientific boundaries for global breakthroughs
ReceptorPharma Inc is a pharmaceutical startup founded in 2017 with a mission to develop new Alzheimer’s drugs through a novel pathway and mechanism. Utilizing the latest research on disease-coupled genes and a well-studied drug target protein family, the company aims to create a new generation of Alzheimer’s disease drugs. This innovative approach serves as their competitive advantage, positioning them at the forefront of drug development for Alzheimer’s and other debilitating diseases, including certain types of cancer. The Seed Round investment in June 2018 from SmiLe Venture Hub signifies the industry's recognition of their potential. With headquarters in the United States, ReceptorPharma is proactively pushing scientific boundaries for global breakthroughs in pharmaceuticals.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | Unknown | 1 |
|
01 Jun 2018 |
No recent news or press coverage available for ReceptorPharma Inc.
We care about your data, and we'd love to use cookies make your experience better.
